Research Article
The Exposure of Phosphatidylserine Influences Procoagulant Activity in Retinal Vein Occlusion by Microparticles, Blood Cells, and Endothelium
Table 1
Characteristics of control subjects and RVO patients.
| | Baseline | Controls () | RVO () |
| | Age (years) | 58.72 ± 9.25 | 60.50 ± 10.25 | | Female sex, (%) | 15 (60) | 18 (72) | | Body mass index (median (kg/m2)) | 23 ± 10 | 26 ± 13 | | Dyslipidemia, (%) | 9 (36) | 10 (40) | | Hypertension, (%) | 10 (40) | 10 (40) | | Smoking, (%) | 14 (56) | 15 (60) | | Retinal vein neovascular | 0 | 5 | | Macular edema | 0 | 8 | | Visual acuity of involved eye, (%) | | | | ≤1/10 | 0 | 17 | | 1/10 to ≤3/10 | 8 | 7 | | >3/10 | 17 | 1 | | Chronic open-angle glaucoma | 0 | 0 | | Laboratory parameters | | | | RBC count (109/l) | 4.23 ± 0.83 | 4.54 ± 0.46 | | WBC count (1012/l) | 5.60 ± 1.15 | 7.04 ± 2.89 | | Plt count (109/l) | 248.35 ± 50.32 | 260.62 ± 87.03 | | D-D (mg/l) | 0.38 ± 0.14 | 0.46 ± 0.34 | | TT (s) | 17.48 ± 1.13 | 18.12 ± 1.67 | | PT (s) | 10.83 ± 0.70 | 11.09 ± 0.73 | | APTT (s) | 27.14 ± 3.41 | 27.78 ± 5.50 | | Fib (g/l) | 2.75 ± 0.55 | 3.40 ± 0.38 |
|
|
versus controls. RVO: retinal vein occlusion. D-D: D-dimers; TT thrombin time; PT: procoagulant time; APTT: activated partial thromboplastin time; Fib: fibrinogen. |
